NEWSROOM

Stock Market

Premier Graphene’s Proprietary Graphene-Modified Asphalt Demonstrates Substantial Stability and Performance Improvements Compared to Conventional Asphalt in Laboratory Tests

Premier Graphene’s Proprietary Graphene-Modified Asphalt Demonstrates Substantial Stability and Performance Improvements Compared to Conventional Asphalt in Laboratory Tests

Aug 29, 2024

Imperial Valley, California, August 29, 2024 – Premier Graphene Inc. (OTC: BIEI), formerly Premier Biomedical Inc., announced today a groundbreaking technical report with significant implications for the road and highway construction industries. Building on our successful integration of our high-grade, efficacious graphene in cement, the testing conducted by Baja California Test S.A. de R.L. de C.V., highlights that the integration of graphene into asphalt mixtures, demonstrates again...

BioStem Technologies Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET

BioStem Technologies Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET

Aug 29, 2024

Advanced wound care MedTech company recently reported a record second-quarter with $116.4M in revenue for H1, 2024 POMPANO BEACH, Fla., Aug. 29, 2024 -- BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, will present at the H.C. Wainwright 26th Annual Global Investment Conference held on September 9th through 11th in New York City at the Lotte Palace Hotel....

BranchOut Food Delivers Shareholder Update: 2024 Revenue Surges 640% in First Half, Poised for Continued Growth and Debt Elimination by Q4 2025

BranchOut Food Delivers Shareholder Update: 2024 Revenue Surges 640% in First Half, Poised for Continued Growth and Debt Elimination by Q4 2025

Aug 28, 2024

BranchOut Food estimated to finish year at $8 million in Net Revenue Net Revenue for 1st half 2024 up over 640% from revenue in 1st half 2023 The Company estimates $5 million in Revenue for 2nd half of 2024, double that of the same period last year, to finish 2024 near $8 million Opening new production facility in Peru with about $40 mm in capacity with first production anticipated in October Completed combined financing of $5.4 million in June and July 2024 to finance completion of new...

BLAQclouds, Inc. Announces Initial Launch of BLAQ Token on BLAQlp.io

BLAQclouds, Inc. Announces Initial Launch of BLAQ Token on BLAQlp.io

Aug 27, 2024

Las Vegas, NV, August 27, 2024 — BLAQclouds, Inc. (OTC: BCDS) is pleased to announce that this week, the company will launch its first liquidity pool partnership on BLAQlp.io with the debut of the BLAQ token on both the Ethereum and ZEUS blockchains. The exact date and time for the launch will be announced with 24 hours prior notice, based on market conditions and other factors. As previously announced, the core smart contract powering BLAQlp.io allows funders to directly contribute to...

Lipella Pharmaceuticals to Participate at H.C. Wainwright’s 26th Annual Global Investment Conference in New York

Lipella Pharmaceuticals to Participate at H.C. Wainwright’s 26th Annual Global Investment Conference in New York

Aug 27, 2024

Company has two lead drug candidates for rare disease indications in IND approved phase 2 clinical trials using the 505(b)(2) pathway Pittsburgh, PA, August 27, 2024 – Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella”) will participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York City at the Lotte New York Palace Hotel on September 9 through 11, 2024. Admission to H.C. Wainwright’s conference is for qualified investors, and Lipella will be giving a virtual...

AmpliTech Group’s AGMDC Division Moves to Allen Tech Hub in Watters Creek District in Allen, Texas

AmpliTech Group’s AGMDC Division Moves to Allen Tech Hub in Watters Creek District in Allen, Texas

Aug 26, 2024

Hauppauge, NY, August 26, 2024 – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced its AmpliTech Group Microwave Design Center move into the prestigious cutting-edge Allen Tech Hub in the heart of...

AB INTL GROUP Announces Repurchase of Common Stock for Cancelation

AB INTL GROUP Announces Repurchase of Common Stock for Cancelation

Aug 26, 2024

NEW YORK, Aug. 26, 2024 - AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, today announced a repurchase of 50,296,980 shares of common stock for cancelation. Its positive cash flow continues to come from net profitability to enable the repurchase of more shares in the near future. On August 21, 2024, AB International Group Corp. (the “Company”) entered into Repurchase Agreements with seven shareholders, all non-affiliates of the...

Halberd Corp. Issues Letter to Shareholders

Halberd Corp. Issues Letter to Shareholders

Aug 26, 2024

JACKSON CENTER, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) today issued the following letter to its shareholders: Halberd Corp. - Taking a Moment to Recenter Our Technical Progress Introducing Tri-ax™ TBI Nasal Spray Treatment- the DoD selected our MSU-led pre-proposal, inviting us to submit a full application/proposal This is the first of a series of three significant Press Releases we plan to issue shortly. Many of our investors have been voicing...

ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility

ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility

Aug 26, 2024

Successful Conversion Eliminates Over $4 Million in Long-Term Debt New York, NY, August 26, 2024 - ANEW MEDICAL, INC. (NASDAQ: WENA), a leading U.S. biotechnology company pioneering cell and gene-based treatments for aging and age-related diseases, announces the successful conversion of its convertible promissory notes by investors. This strategic move significantly strengthens ANEW’s balance sheet by eliminating over $4 million in long-term debt. The elimination of over $4 million in...

Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research

Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research

Aug 22, 2024

Affecting about 6 million Americans, OLP is a chronic inflammatory disease affecting the mucous membranes of the mouth No FDA-approved therapy currently exists for OLP Patient registry and OLP study information is now available Pittsburgh, PA, August 22, 2024 – Lipella Pharmaceuticals, Inc. (NASDAQ: LIPO) has launched an Oral Lichen Planus (OLP) Patient Registry. This online platform is designed to enhance research and drive the development of new treatments for OLP, a chronic inflammatory...

BioStem Technologies Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET

BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje® Compared to the Standard of Care for Non-Healing Diabetic Foot Ulcers

Aug 21, 2024

Study supports BioStem’s strategic growth initiatives and accelerates product adoption by providing data to healthcare professionals and payers on the benefits of Vendaje POMPANO BEACH, FL, August 21, 2024 - BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces that the Institutional Review Board (IRB) has approved a clinical study to evaluate Vendaje® for...

ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility

ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)

Aug 21, 2024

New York, NY. August 21, 2024 - ANEW MEDICAL, INC. (“ANEW” or the “Company”) (NASDAQ: WENA), announced the signing of an exclusive worldwide license agreement with Transfertech Sherbrooke(“TTS”)regarding Nanoject, a needle-free, freeze-dried nanopowder autoinjector for medicines and vaccines. Needle phobia and injection or blood-drawing anxiety are prevalent among adults and children, creating barriers to adhering to doctor visits and medication protocols. Alternatives to needle/syringes have...

Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research

Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference

Aug 21, 2024

LP-20 contrast agent designed to diagnose interstitial cystitis and detect bladder cancer Novel MRI contrast agent, which received support from National Institute of Diabetes and Digestive and Kidney Diseases 5th International Consultation on Interstitial Cystitis Japan runs Aug. 21-23 in Kyoto Pittsburgh, PA, August 21, 2024 – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotech company, will highlight clinical data on LP-20, a novel MRI contrast agent designed for diagnosing...

AB INTL GROUP Announces Repurchase of Common Stock for Cancelation

AB INTL GROUP Announces Business Updates

Aug 20, 2024

NEW YORK, August 20, 2024 -- AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, today announced business updates. Achieved net profitability in latest quarter ending on May 31, 2024. **Financial Performance**: - Recent financial reports indicate a focus on increasing revenues while reducing expenses, leading to net profitability. For the period ending May 31, 2024, the Company reported a significant increase in revenue and a...

AmpliTech Group’s AGMDC Division Moves to Allen Tech Hub in Watters Creek District in Allen, Texas

AmpliTech Group To Hold Q2-2024 Investor’s Conference Call

Aug 20, 2024

Hauppauge, NY, August 20, 2024 – AmpliTech Group, Inc (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced the company will host an investor conference call on Wednesday, August 28th, 2024 at 5:00 PM ET. Investor Earnings...

AmpliTech Group’s AGMDC Division Moves to Allen Tech Hub in Watters Creek District in Allen, Texas

AmpliTech Group’s AGTGSS Division Signs Memorandum Of Understanding For Initial Domestic Private 5G Network Deployment

Aug 20, 2024

With Domestic IP Data Networking, Power Storage, Cybersecurity, and IoT Company Hauppauge, NY, August 20, 2024 – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced the signing of a Memorandum of...

SMCE (OTC: SMCE) Announces Launch of Chaintrade, its AI-Powered Platform Revolutionizing Data Intelligence in Capital Markets

SMCE (OTC: SMCE) Announces Launch of Chaintrade, its AI-Powered Platform Revolutionizing Data Intelligence in Capital Markets

Aug 20, 2024

Boca Raton, August 20, 2024 – SMCE (OTC: SMCE), a pioneer in financial technology, proudly announces the launch of Chaintrade.ai, an advanced AI-powered platform designed to revolutionize data intelligence for the capital markets. With a suite of vertically focused AI applications, Chaintrade.ai is set to transform how investors, analysts, and financial institutions access, analyze, and leverage market data, driving smarter decisions and fostering innovation across the industry. From...

BLAQclouds, Inc. Provides Update On BLAQlp.io

BLAQclouds, Inc. Provides Update On BLAQlp.io

Aug 19, 2024

Las Vegas, NV, August 19, 2024 — BLAQclouds, Inc. (OTC: BCDS) is pleased to announce the launch of version 1 of its BLAQlp.io DaPP, as well as an update on the recently announced LOI to acquire ZEUS Blockchain Partners, Inc. On August 18, 2024, BLAQclouds unveiled BLAQlp.io, an innovative platform that enables private funds, family offices, institutional investors, high-net-worth individuals, and accredited funders to participate in its open-source protocol to create non-custodial liquidity...

Ethical Web AI announces that its Ethical Web product is now demonstrable

Ethical Web AI announces that its Ethical Web product is now demonstrable

Aug 19, 2024

NEW YORK, August 19, 2024 – Bubblr Inc., d/b/a Ethical Web AI (OTC: BBLR) - a frontrunner in ethical technology determined to revolutionize the digital domain, has announced that its Ethical Web product is now demonstrable. The Ethical Web platform has been in development for over three years. It is the technical manifestation of its highly valued granted US patent 10977387. Established internet search engines have not really changed in over 30 years. This new platform allows licensees to...

SKYX to Collaborate with EGLO, European World Leading Design and Manufacturer of Decorative Lighting and Ceiling Fans

SKYX to Collaborate with EGLO, European World Leading Design and Manufacturer of Decorative Lighting and Ceiling Fans

Aug 19, 2024

The Collaboration Provides for the Joint Exploration and Product Development Potential for European and International markets for leveraging SKYX’s Technology, Product and Manufacturing Expertise of the Two Companies MIAMI, FL, August 19, 2024 - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the "Company" or "SKYX"), a highly disruptive smart platform technology company with more than 97 issued and pending patents globally and over 60 lighting and home décor websites, announces...

ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility

ANEW MEDICAL, INC. Appoints New CFO

Aug 19, 2024

New York, NY, August 19, 2024 - ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ: WENA) a U.S.-based biotechnology company focused on developing cell and gene-based treatments for aging, and age-related diseases, today announced the appointment of Jeffrey LeBlanc as the company’s Chief Financial Officer (CFO), replacing the interim CFO, Edward Cong Wang who was the former CFO of Redwoods Acquisition Corp into which ANEW merged. “Jeff LeBlanc is a highly experienced senior executive, and we...

Sono-Tek to Present at August 20th Virtual Investor Summit Microcap Event

Sono-Tek to Present at August 20th Virtual Investor Summit Microcap Event

Aug 15, 2024

MILTON, NY, August 15, 2024 — Sono-Tek Corporation (Nasdaq: SOTK), a leading developer and manufacturer of ultrasonic coating systems, announced today that it will be presenting at the upcoming Virtual Investor Summit on August 20, 2024. Investors may request a one-on-one meeting with management by registering here: https://investorsummitgroup.com. Event: Q3 Investor SummitDate: August 20, 2024Presentation Time: 1:30 PM ETLocation: https://www.webcaster4.com/Webcast/Page/3062/51124 About...

ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility

ANEW MEDICAL, INC. Strengthens Intellectual Property Protection with U.S. Patent Issuance for Its Secreted RNA Splice Variant of the Human Klotho Gene Used for the Treatment of Neurodegenerative and Age-Related Diseases

Aug 15, 2024

Issuance of the Klotho gene-therapy patent will be instrumental in protecting ANEW’s IP for development and commercialization in the U.S. New York, NY, August 15, 2024 - ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ: WENA), a U.S.-based biotechnology company focused on developing cell and gene-based treatments for aging and age-related diseases; today announced the grant and issuance of U.S. Patent No. 12,036,268 (“the 268 patent”) covering the secreted RNA splice variant of the human...

AmpliTech Group’s AGMDC Division Moves to Allen Tech Hub in Watters Creek District in Allen, Texas

AmpliTech Group Reports Q2 Revenue of $2.5M with 1.05M Gross Profits and 42% Gross Margins

Aug 14, 2024

Hauppauge, NY, August 14, 2024 – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced its financial results for the second quarter ended June 30, 2024. The company plans to host an investor call within...

American Shared Hospital Services Announces Second Quarter 2024 Earnings Conference Call

American Shared Hospital Services Announces Second Quarter 2024 Earnings Conference Call

Aug 14, 2024

Call Scheduled for Today at 6:30 PM ET SAN FRANCISCO, August 14, 2024 - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that the Company will hold a conference call to discuss its second quarter 2024 financial results today, August 14th at 6:30 pm ET / 3:30 pm PT. The second quarter 2024 financial results press release...

Formation Minerals, Inc. Provides Fiscal Year End Corporate Update

Formation Minerals, Inc. Provides Fiscal Year End Corporate Update

Aug 14, 2024

Jacksboro, Texas, August 14, 2024 – Formation Minerals, Inc. (OTCQB: FOMI) (“Formation” or the “Company”), a growing oil and gas company with a focus on the acquisition and management of oil and gas minerals and royalties, today provided its fiscal year-end stockholder update. To our valued friends and stockholders, We hope that this letter finds you well and enjoying the summer. We at Formation continue to execute our strategy and are pleased to provide a corporate update in connection with...

Metatron Announces QuantumBeam – A Revolution in AI-Controlled Energy Transmission

Metatron Announces QuantumBeam – A Revolution in AI-Controlled Energy Transmission

Aug 13, 2024

Dover, DE, August 13th, 2024 – Metatron Apps Inc (OTC: MRNJ) ($MRNJ), leading developer of over 1000 mobile apps proudly introduces QuantumBeam, a groundbreaking service that harnesses AI-designed and controlled cloud technology to deliver continuous energy transmission through quantum entanglement. This cutting-edge platform offers unparalleled benefits such as enhanced vitality, stress reduction, and EMF mitigation, backed by rigorous scientific studies demonstrating its effectiveness....

Sono-Tek to Present at August 20th Virtual Investor Summit Microcap Event

Sono-Tek Announces Additional $2.95 Million Order from Specialty Clean Energy Customer

Aug 13, 2024

4 System Order Expected to be Shipped in Fiscal 2026 Company Experiencing Strong Demand from Clean Energy Sector MILTON, NY, August 13, 2024 — Sono-Tek Corporation (Nasdaq: SOTK), a leading developer and manufacturer of ultrasonic coating systems, is pleased to announce the receipt of an additional $2.95 million order from an existing clean energy customer. This new order, identical in value and scope to a recent record-breaking order from the same customer, reinforces Sono-Tek’s position as a...

Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study

Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study

Aug 12, 2024

Case Series represents second study showing VitaGraft Kidney as a measure of response to the benefit of therapy for one leading cause of allograft failure IRVINE, Calif., August 12, 2024 — Oncocyte Corp. (Nasdaq: OCX), a molecular diagnostics technology company, announced the recent publication of a case series of two kidney transplant patients who were monitored for antibody-mediated rejection (AMR) using its proprietary VitaGraft™ Kidney diagnostic test. Patients were tested before, during...

BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million

BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million

Aug 12, 2024

Company reports transformative second-quarter revenue, contributing to a record total of $116.4 million in revenue for the first half of 2024 AmnioWrap2 continues to be a major growth driver achieving an impressive 56.5% sequential revenue increase compared to Q1 2024 Achieves second consecutive quarter of positive net income with $6.3 million Generated Adjusted Q2 2024 EBITDA of $10.0 million Financial Results Conference Call and Webcast on Monday, August 12, 2024, at 4:30 pm EDT POMPANO...